Literature DB >> 14014741

Teratogenic effects of thalidomide and related substances.

J B BOYLEN, H H HORNE, W J JOHNSON.   

Abstract

Entities:  

Keywords:  ABNORMALITIES; THALIDOMIDE

Mesh：

Substances：

Year:  1963        PMID： 14014741     DOI： 10.1016/s0140-6736(63)91346-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1. 

Authors:  Inge Koch; Rolf Heydecke
Journal:  Wilhelm Roux Arch Entwickl Mech Org       Date:  1967-06

2.  The metabolism of thalidomide: the fate of thalidomide and some of its hydrolysis products in various species.

Authors:  H Schumacher; R L Smith; R T Williams
Journal:  Br J Pharmacol Chemother       Date:  1965-10

Review 3.  Chemical 'Jekyll and Hyde's: small-molecule inhibitors of developmental signaling pathways.

Authors:  Tomoyo Sakata; James K Chen
Journal:  Chem Soc Rev       Date:  2011-04-19       Impact factor: 54.564

Review 4.  Practical guidance for new multiple myeloma treatment regimens: A nursing perspective.

Authors:  Monica Epstein; Candis Morrison
Journal:  Semin Oncol       Date:  2022-02-10       Impact factor: 5.385

5.  Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation.

Authors:  Christina Therapontos; Lynda Erskine; Erin R Gardner; William D Figg; Neil Vargesson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-11       Impact factor: 11.205

Review 6.  Thalidomide-induced teratogenesis: history and mechanisms.

Authors:  Neil Vargesson
Journal:  Birth Defects Res C Embryo Today       Date:  2015-06-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.